دورية أكاديمية
Prevalence of dyslipidemia, hypertension and diabetes among tribal and rural population in a south Indian forested region.
| العنوان: | Prevalence of dyslipidemia, hypertension and diabetes among tribal and rural population in a south Indian forested region. |
|---|---|
| المؤلفون: | Mallikarjuna Majgi S; Department of Community Medicine, Mysore Medical College and Research Institute, Mysore, India., Channa Basappa Y; Health Equity Cluster, Institute Public Health, Bengaluru, India., Belagihalli Manjegowda S; Research Scientist II, Multi-Disciplinary Research Unit, Mysore Medical College and Research, Mysore, India., Nageshappa S; Research Scientist-I, Multi-Disciplinary Research Unit, Mysore Medical College and Research, Mysore, India., Suresh H; Research Fellow, SingHealth Duke-NUS Global Health Institute, Singapore, Singapore., Babu GR; Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar., Srinivas PN; Health Equity Cluster, Institute Public Health, Bengaluru, India. |
| المصدر: | PLOS global public health [PLOS Glob Public Health] 2024 May 20; Vol. 4 (5), pp. e0002807. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: San Francisco, California : Public Library of Science, [2021]- |
| مستخلص: | While NCDs are in rise globally, tribal and rural populations residing near to reserve forests with limited exposure to modern lifestyles may bear a unique burden. This study investigates the prevalence and risk factors of hypertension, diabetes, and dyslipidemia among these communities. We conducted a cross-sectional study between 2018 and 2020 in the forest-dwelling population of Chamarajanagar, India. Using multistage stratified sampling based on caste and remoteness, we enrolled 608 participants aged over 18 years, including 259 non-tribal and 349 tribal individuals. Data collection includes the administration of STEPS questionnaire and measurement of fasting blood sugar, lipid levels, and blood pressure. The prevalence of diabetes, hypertension, and dyslipidemia were 4.6%, 28.8%, and 85.7%, respectively, among the study population. We also found abnormal levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), Triglycerides (TGA), Total cholesterol (TC), and very low-density lipoprotein (VLDL)in 4.9%, 82.4%, 22.7%, 5.8%, and 7.4% of participants, respectively. Significant differences were observed in diabetes, LDL abnormality, TGA abnormality, VLDL abnormality, and TC abnormality, but not in hypertension, dyslipidemia, or HDL abnormality, across the Socio Geographic Discrimination Index. We found a significant difference in diabetes and HDL abnormality, but not in hypertension, dyslipidemia, LDL abnormality, TGA abnormality, TC abnormality, or VLDL abnormality, between tribal and non-tribal populations living in the forest-dwelling area. Waist circumference was a significant independent predictor of diabetes among tribal participants, while wealth index, age, and waist circumference were significant predictors of hypertension. There were no significant predictors for dyslipidemia among tribal participants. Our study suggests that tribal population living in a remote area are at a lower risk of developing diabetes compared to non-tribal populations living in the same geographic area. However, the prevalence of hypertension and dyslipidemia among tribal populations remains high and comparable to that of the general population. Competing Interests: The authors have declared that no competing interests exist. (Copyright: © 2024 Mallikarjuna Majgi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.) |
| References: | Indian J Med Res. 2015 May;141(5):673-87. (PMID: 26139788) J Racial Ethn Health Disparities. 2024 Feb;11(1):451-467. (PMID: 36752902) Lancet Glob Health. 2018 Dec;6(12):e1339-e1351. (PMID: 30219317) J Postgrad Med. 2017 Apr-Jun;63(2):106-113. (PMID: 27853041) BMC Public Health. 2016 May 25;16:434. (PMID: 27225632) Curr Dev Nutr. 2022 Sep 13;6(9):nzac102. (PMID: 36110104) Diabetes Metab Syndr. 2019 Sep - Oct;13(5):2961-2966. (PMID: 31425964) Int J Health Serv. 2022 Jan;52(1):61-72. (PMID: 32787539) Diabetes Res Clin Pract. 2013 Oct;102(1):1-7. (PMID: 23876547) Indian J Med Res. 2014 Sep;140(3):370-8. (PMID: 25366204) Lancet. 2004 Jan 10;363(9403):157-63. (PMID: 14726171) JAMA. 2014 Feb 5;311(5):507-20. (PMID: 24352797) Ethn Dis. 2004 Spring;14(2):250-9. (PMID: 15132211) PLoS One. 2021 Mar 2;16(3):e0246712. (PMID: 33651825) Ethn Health. 2023 May;28(4):544-561. (PMID: 35469488) Indian Heart J. 2016 Sep - Oct;68(5):655-662. (PMID: 27773404) J Postgrad Med. 2012 Oct-Dec;58(4):255-61. (PMID: 23298919) Global Health. 2006 Mar 28;2:4. (PMID: 16569239) Lancet. 2005 Jan 15-21;365(9455):217-23. (PMID: 15652604) Lancet. 2011 Mar 5;377(9768):790-2. (PMID: 21227488) Int J Chronic Dis. 2014;2014:380597. (PMID: 26464856) Indian J Public Health. 2008 Jul-Sep;52(3):144-6. (PMID: 19189836) Diabetes Res Clin Pract. 2020 Nov;169:108457. (PMID: 32979420) Am J Hum Biol. 2019 Sep;31(5):e23263. (PMID: 31197927) Biochem Res Int. 2013;2013:696845. (PMID: 24455263) Indian J Endocrinol Metab. 2021 Jul-Aug;25(4):313-319. (PMID: 35136738) PLoS One. 2014 May 05;9(5):e95896. (PMID: 24797244) Wellcome Open Res. 2019 Dec 13;4:202. (PMID: 32211518) Indian J Med Res. 2006 May;123(5):679-86. (PMID: 16873911) Indian Heart J. 2018 Sep - Oct;70(5):598-603. (PMID: 30392494) J Family Med Prim Care. 2020 Sep 30;9(9):4929-4935. (PMID: 33209824) J Postgrad Med. 2018 Jan-Mar;64(1):23-34. (PMID: 29386415) Indian J Community Med. 2019 Oct-Dec;44(4):342-346. (PMID: 31802797) Indian J Med Res. 2015 May;141(5):697-708. (PMID: 26139790) Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1105-1115. (PMID: 31336452) Indian J Med Res. 2011 Mar;133:287-93. (PMID: 21441682) Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596. (PMID: 28601585) Diabetes Metab Syndr. 2015 Oct-Dec;9(4):205-9. (PMID: 26359305) Gene. 2020 Dec;763S:100026. (PMID: 34493361) Scientifica (Cairo). 2016;2016:3589720. (PMID: 26989560) Natl Med J India. 2004 Nov-Dec;17(6):300-4. (PMID: 15736549) Pathog Glob Health. 2017 Oct;111(7):343-350. (PMID: 29139339) |
| تواريخ الأحداث: | Date Created: 20240520 Latest Revision: 20240522 |
| رمز التحديث: | 20240522 |
| مُعرف محوري في PubMed: | PMC11104681 |
| DOI: | 10.1371/journal.pgph.0002807 |
| PMID: | 38768141 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2767-3375 |
|---|---|
| DOI: | 10.1371/journal.pgph.0002807 |